We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Conviction Of Insys Execs Will Embolden Gov't In Opioid Fight

Law360, Boston (May 3, 2019, 8:11 PM EDT) -- A Boston jury sent a message that will both resonate in the pharmaceutical industry and embolden already aggressive opioid prosecutions when it convicted five former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, experts said after Thursday's landmark verdict.

The case marked the first successful prosecution of a top executive tied to addictive painkillers, and observers of the closely watched proceeding said it will lead to more corporate bigwigs getting in the government’s crosshairs.

“A prosecutor who is looking at a case with similar facts and similar underlying conduct is certainly going to be more emboldened to press charges, to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS